Welcome to MIT NEWDIGS

MIT’s NEW Drug Development ParadIGmS (NEWDIGS) program is a unique collaborative “think and do” tank focused on enhancing the capacity of the global biomedical innovation system to reliably and sustainably deliver new, better, affordable therapeutics to the right patients faster. MIT NEWDIGS takes a systems approach to designing, evaluating and catalyzing important advancements that are so complex and cross-cutting that they cannot be addressed by a single organization or market sector. Its first project area was focused on catalyzing the evolution of global pharmaceutical regulation.

Developing and delivering new, effective and affordable drugs to patients is a complex challenge involving manufacturers, regulators, payers, providers, academic researchers and patients—all of whom are operating within a dynamic social, political and economic environment. While the approach that each stakeholder takes may be appropriate in isolation, the divergent actions within this innovation ecosystem compromise our collective ability to serve the needs of patients effectively.

By bringing together diverse collaborators within a safe haven setting, and leveraging MIT expertise in systems engineering, this group is well positioned to inform and enable meaningful high-impact change involving the coordinated evolution of technologies, processes, policies, and people required to achieve its mission.

The MIT Center for Biomedical Innovation (CBI) provides program leadership and serves as the neutral intermediary for the pre-competitive activities within NEWDIGS.

NEWDIGS has been approached by a number of parties to replicate its work in regulation to address other complex, system-level challenges in biomedical and healthcare innovation. Updates on new areas of activity within NEWDIGS are anticipated within the coming months.


eNewsletter sign Up

eNewsletter sign Up

Subscribe to our newsletter and keep up to date with all the latest from NEWDIGS on your pc, tablet or mobile.
Subcribe Now


Become a NEWDIGS member and gain access to resources, publications and more.
For details of how to join Click here.
Already a Member, Log In now.

Latest News

NEWDIGS at DIA 2016NEWDIGS Executive Director Gigi Hirsch Co-Chairs, Keynotes DIA 2016 in Philadelphia, June 26-30.
Read more about DIA 2016

Member news

EURORDIS joins MIT NEWDIGS consortium to accelerate discovery and adoption of new medicines
International collaboration aims to improve healthcare for people living with a rare disease
Listen to Gigi Hirsch discuss the challenges to rapid medical innovation in this DIA Global Focus podcast, with Deputy Editor Alberto Grignolo.

Gigi Hirsch with Alberto Grignolo on DIA Global Forum Podcast: “An Urgent Imperative Now to Learn Quickly”

Published on June 17, 2016

Listen to a conversation between Dr. Alberto Grignolo, Deputy Editor of DIA Global Forum, and NEWDIGS Executive Director and DIA 2016 Conference Co-Chair Dr. Gigi Hirsch discuss the challenges of healthcare system redesign in an era of groundbreaking science and new medical therapies.

Dr Hirsch is also participating in the DIA 2016 panel discussion “Europe and the US: Making Outcomes-Based Health Care Possible”.

Get the podcast

See the panel discussion agenda